Journal
INVESTIGATIONAL NEW DRUGS
Volume 28, Issue 1, Pages 35-48Publisher
SPRINGER
DOI: 10.1007/s10637-008-9212-6
Keywords
Chemotherapy; Double-strand breaks; Cytotoxicity; DNA damage; Anticancer drug
Categories
Funding
- Lady Tata Memorial Trust international award for leukemia research, London
- DBT, India [BT/PRS129/GBD/27/7/2006]
- IISc start up grant
- CSIR, India
Ask authors/readers for more resources
DNA intercalators are one of the most commonly used chemotherapeutic agents. Novel intercalating compounds of pyrimido[4',5':4,5]selenolo(2,3-b)quinoline series having a butylamino or piperazino group at fourth position (BPSQ and PPSQ, respectively) are studied. Our results showed that BPSQ induced cytotoxicity whereas PPSQ was cytostatic. The cytotoxicity induced by BPSQ was concentration- and time-dependent. Cell cycle analysis and tritiated thymidine assay revealed that BPSQ affects the cell cycle progression by arresting at S phase. The absence of p-histone H3 and reduction in the levels of PCNA in the cells treated with BPSQ further confirmed the cell cycle arrest. Further, annexin V staining, DNA fragmentation, nuclear condensation and changes in the expression levels of BCL2/BAD confirmed the activation of apoptosis. Activation of caspase 8 and lack of cleavage of caspase 9, caspase 3 and PARP suggest the possibility of BPSQ triggering extrinsic pathway for induction of apoptosis, which is discussed. Hence, we have identified a novel compound which would have clinical relevance in cancer chemotherapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available